
Theracys (BCG Live (Intravesical)): Side Effects, Uses, Dosage ... - RxList
2023年5月23日 · TheraCys, BCG Live (Intravesical) is a freeze-dried preparation made from the Connaught strain of Bacillus Calmette and Guérin, which is an attenuated strain of …
TheraCys: Indications, Side Effects, Warnings - Drugs.com
2024年1月29日 · Uses of TheraCys: It is used to treat bladder cancer. What do I need to tell my doctor BEFORE I take TheraCys? If you have an allergy to BCG or any other part of this …
Bacillus Calmette-Guerin (BCG, TICE®, TheraCys®) - OncoLink
2023年8月3日 · About Bacillus Calmette-Guerin (BCG, TICE®, TheraCys®) Bacillus Calmette-Guerin (BCG) is a weakened strain of Mycobacterium bovis, which can be used to prevent …
BCG Live Intravesical: Uses, Side Effects, Interactions ... - WebMD
Tell your doctor right away if you have any serious side effects, including: signs of bladder irritation (such as difficult/painful/frequent/bloody urination), muscle/ joint pain, pain/swelling of...
Bacillus Calmette-Guerin Live, BCG intravesical solution - Cleveland Clinic
COMMON BRAND NAME(S): Theracys, TICE BCG. What should I tell my care team before I take this medication? They need to know if you have any of these conditions: •aneurysm •blood in …
BCG (Therasys) for Bladder Cancer | ChemoExperts
BCG is designed to promote an inflammatory response in the lining of the bladder where the cancer is located. This inflammatory response recruits white blood cells of the immune system …
TheraCys - Chemocare
此藥物可透過導管注入膀胱。 此藥物在醫院或診所中,由受過特殊訓練的專業醫護人員監管。 治療之前會提供指示給您,供您遵循。 小心遵循您醫師或專業醫護人員提供的指示。 此藥物含 …
BCG (Intravesical) (Professional Patient Advice) - Drugs.com
2024年4月4日 · TheraCys [DSC] Tice BCG; Pharmacologic Category. Antineoplastic Agent, Biological Response Modulator; Pharmacology. BCG (intravesical) is an attenuated strain of …
BCG intravesical Uses, Side Effects & Warnings - Drugs.com
2024年4月26日 · BCG (Bacillus Calmette and Guérin) is a freeze-dried product made from bacteria. BCG increases certain white blood cells that destroy invading tumor cells in the …
TheraCys is indicated for intravesical use in the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder and for the prophylaxis of primary or recurrent stage Ta and/or T1 …
- 某些结果已被删除